Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
about
The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in micealpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitroTargeting the Notch signaling pathway in cancer therapeuticsSurface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic targetGlobal gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progressionGenetically determined proteolytic cleavage modulates alpha7beta1 integrin function.Differential roles of uPAR in peritoneal ovarian carcinomatosisDependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer.Text mining of full-text journal articles combined with gene expression analysis reveals a relationship between sphingosine-1-phosphate and invasiveness of a glioblastoma cell line.Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomasInhibitors of urokinase type plasminogen activator and cytostatic activity from crude plants extracts.Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas.HuR: a promising therapeutic target for angiogenesisPlasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescenceOverexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts.PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysisThe molecular pathogenesis of osteosarcoma: a reviewA novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature.RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays.Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity.Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.Comparative proteome analysis of human epithelial ovarian cancer.Synthesis and biological characterization of protease-activated prodrugs of doxazolidineRole of integrins in regulating proteases to mediate extracellular matrix remodelingRole of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effectsOpposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancyEnhanced progression of human prostate cancer PC3 cells induced by the microenvironment of the seminal vesicle.Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.Role of urokinase receptor in tumor progression and development.Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity.Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.
P2860
Q21195231-7010B8FB-6585-435D-84EB-EEF27F56D69CQ24561588-051B5848-D4C0-4223-B709-BEA0ABE1F7E9Q24792711-0BB48FA2-1886-405E-BF7C-DDA336BFFE0FQ26863580-BD7C085A-DADB-45DF-9FCC-FC521C24CB84Q27311163-ECB5BD58-DCFD-4801-9BD3-BCD7A6D2F326Q30157655-55B3209B-583E-473D-9CA0-F1D0CB3EFCAFQ30372842-E9301CC9-B485-46E7-8FBC-33D2C3ECD4C7Q30426956-DA799294-8B68-42FD-B962-E2DBEE418472Q30502082-10D9B732-CF35-4112-BD1C-2AE7ED4CFA32Q33253539-89D9A758-F3CD-4AE1-92E3-409879C3D9D1Q33559079-A67C2E20-913B-4B09-A439-96922C2B3DC5Q33664568-0FBB4914-348C-4D22-AA0A-20A2C6436036Q33869014-A404E0AB-C335-49A7-A355-1A3FBDEE10B0Q34070037-DEB13D04-7DF8-4EA2-B88D-3C32F2316CBDQ34196515-B0900644-9704-4FDD-89C2-9A00940807B1Q34475106-A2BF0CD7-2128-42FE-BC2A-49C23903AF6DQ34599478-42A474CA-BE57-4126-B1E4-66D592CA803AQ34629074-C8733B15-B8EB-486C-980A-097128DBE55EQ34993336-D144647E-7FDF-4DB3-8EF9-047B7DFB7F57Q35130808-0CEA9F73-D179-4914-88FD-D2CF291B9B07Q35166017-78B2A399-8000-47D7-A2D1-E38DC994751AQ35678791-27718A19-B578-4AAB-849D-C595D9C0C956Q35713784-434835C1-27D6-4EA5-9795-6B4652D9368AQ35781926-398B6D02-E71D-4A5D-9633-5E64F4B8BD31Q35789112-9E8E5FD9-723C-469B-A64C-1A2F2744D8D9Q36131119-E07DAC41-C665-482E-8C43-3C39C972CF8AQ36206886-1115BAC9-8B0F-4636-B651-2D2334AB01B4Q36284931-1CA9C41B-6FC4-406D-843D-01612DDE206DQ36391616-388BA39E-474E-4DF7-A95A-7F34BD1CA8A2Q36575331-BD144D8C-49CC-446F-8BCE-9C5FE44C539CQ36614744-0565877F-8B27-4059-808A-5763E79AA92DQ36640228-ADC32644-A8D7-415C-82FD-6D12CDB03982Q36997616-E9A245BC-EAF6-463B-86AA-256411707D17Q37057176-33AB5CB2-5A29-44AB-9EFE-BAD355313278Q37063998-1B8FDF6D-EE6B-40F0-945F-2558A946E976Q37103981-7DBFDA18-E6B0-449C-B162-E0BED7F874F3Q37219827-6584BAB6-0977-42E9-B2B5-12C723A2A54DQ37313387-FD529EFB-6CAC-4E29-8AF3-7D72D186750AQ37336713-86C0D26C-16EA-45DD-AA17-0D74139B0D14Q37353288-B240E3B7-E249-46FF-96FB-D99940448B89
P2860
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Urokinase plasminogen activato ...... or progression and metastasis.
@ast
Urokinase plasminogen activato ...... or progression and metastasis.
@en
type
label
Urokinase plasminogen activato ...... or progression and metastasis.
@ast
Urokinase plasminogen activato ...... or progression and metastasis.
@en
prefLabel
Urokinase plasminogen activato ...... or progression and metastasis.
@ast
Urokinase plasminogen activato ...... or progression and metastasis.
@en
P1476
Urokinase plasminogen activato ...... mor progression and metastasis
@en
P2093
Anne P W Nadesapillai
P304
P356
10.1097/01.BLO.0000093845.72468.BD
P407
P433
P50
P577
2003-10-01T00:00:00Z